According to Agomab Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ1.00. In 2024 the company made an earnings per share (EPS) of -ยฃ1.00 a decrease over its 2023 EPS that were of -ยฃ0.26.